Resource Hub
From Months to Minutes: Can AI Really Transform Regulatory Submissions?
From Months to Minutes: Can AI Really Transform Regulatory Submissions? For regulatory professionals, the idea of cutting hundreds of hours of painstaking work down to just a few clicks has always felt out of reach. Imagine Module 2 and Module 3 documents generated directly from data. Product labels compared across
Immunic Therapeutics Selects CARA Life Sciences Platform to Streamline Regulatory Operations and Accelerate Submissions
Immunic Therapeutics Selects CARA Life Sciences Platform to Streamline Regulatory Operations and Accelerate Submissions CARA Life Sciences Platform Adoption Continues to Grow with Biotech Organisation Immunic Therapeutics Generis, the creator of the CARA Life Sciences Platform, today announced that Immunic, a fast-growing biotechnology company focused on treatments for immunologic diseases,
CARA Platform Migration Guide with DAQUMA
We know that migrating from complex, entrenched legacy systems can be daunting – especially when you’re managing large volumes of data and critical processes. That’s why we’ve teamed up with our trusted migration partners at DAQUMA to create a short migration guide for the CARA Platform. This high-level guide unpacks
Loba Biotech GmbH Selects CARA Life Sciences Platform for Digital Quality Management
Loba biotech GmbH, a wholly owned GMP manufacturing subsidiary of pharmaand GmbH (pharma&), has chosen Generis’ CARA Life Sciences Platform to launch its digital Quality Management System (QMS). The initial phase will focus on digitalizing Standard Operating Procedures (SOPs) and implementing the training module, with a go-live target set for
CARA Platform Gains Global Momentum as Generis Unlocks Record Implementation Speeds
AI-powered CARA Platform and new Starter Pack Model fuel rapid expansion across regulated sectors LONDON, UK – Generis, creator of the CARA Platform and CARA Life Sciences Platform, is continuing to accelerate its momentum across both Life Sciences and a growing portfolio of other highly regulated industries. Known for its
AI for LifeSciences – Data & Documentation
Life sciences runs on documentation and data. AI is changing how we manage it. From regulatory filings to clinical research, data is growing exponentially. AI is the key to structuring, retrieving, and using it efficiently. In a rapidly evolving global market, Generis’ latest AI innovations are advancing operational efficiency, compliance,
Cytonics Selects CARA Life Sciences Platform for Rapid eTMF System Implementation
Cytonics, a biotechnology research and development company specializing in diagnostics and therapeutics for osteoarthritis, has selected Generis, the provider of the AI-enabled CARA Life Sciences Platform, to manage its electronic Trial Master File (eTMF) and enhance operational efficiency and productivity. Faced with a need for rapid implementation, Cytonics sought a
Kwizda Pharma Adopts CARA Life Sciences Platform for Rapid QMS Implementation with Minimal IT Resources
Kwizda Pharma, a division of Kwizda Holding GmbH and a leader in the Austrian healthcare market, has selected the CARA Life Sciences Platform from Generis, leading provider of CARA Platform for Content and Data management, to digitise and streamline Quality processes. With over 170 years of experience in the pharmaceutical
eTMF Archive on the CARA Life Sciences Platform
eTMF Archive on the CARA Life Sciences Platform The CARA Life Sciences Platform offers a comprehensive Electronic Trial Master File (eTMF) Archive, designed to enhance the management, accessibility, and compliance of your clinical documentation. By integrating advanced automation, seamless collaboration, and robust compliance features, CARA empowers life sciences companies to
